Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

PTPI

Petros Pharmaceuticals, Inc.

Healthcare · USD

Set alert

Price alert · PTPI

All alert types
0.00 USD 0.00 0.00%
As of Oct 30, 2026 Extended hours 0.04 +1,900.00%
Bid
0.06 × 141,820
Ask
0.06 × 85,710
0.002 Day range 0.0024
0.002 52-week range 0.023
YTD
-75.00%
1 year
-90.00%
Open
0.002
Prev close
0.002
Mkt cap
84.74K
Vol
64.10K
Avg vol
134.13K
EPS
0.08
P/E
0.03
Div yield
0.00%
More statistics
Low
0.002
High
0.0024
Forward P/E
-0.26
Beta
2.28
Short ratio
0.72
Inst. own
2.29%
Dividend
0.00
Ex-div date
50-d avg
0.32284
200-d avg
0.5288
1y target
0.00

5D chart

Chart tools
Interval
1m5m15m30m
PTPI five-day price chart0.000.000.000.000.00Oct 23Oct 26Oct 27Oct 28Oct 29

Financial health

Altman Z-Score

-47.47 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

0 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

B3 / 5 overall

  • DCF 5
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 4
  • P/B 5

Valuation

P/E -0.0×
FY 2018: -3.1×FY 2019: -7.5×FY 2020: -28.5×FY 2021: -101×FY 2022: -6.0×FY 2023: -5.6×FY 2024: -2.9×FY 2025: -0.0×
FY 2018 5y median -5.6× FY 2025
P/S 0.0×
FY 2018: 7.1×FY 2019: 15.8×FY 2020: 61.5×FY 2021: 116×FY 2022: 20.1×FY 2023: 7.8×FY 2024: 15.5×FY 2025: 0.0×
FY 2018 5y median 15.5× FY 2025
P/B 0.8×
FY 2018: -59.3×FY 2019: 30.6×FY 2020: 33.6×FY 2021: 25.5×FY 2022: 7.2×FY 2023: 3.6×FY 2024: -10.6×FY 2025: 0.8×
FY 2018 5y median 3.6× FY 2025
P/FCF -0.3×
FY 2018: 16.2×FY 2019: 99.7×FY 2020: -38.4×FY 2021: -76.4×FY 2022: -9.4×FY 2023: -5.9×FY 2024: -30.1×FY 2025: -0.3×
FY 2018 5y median -9.4× FY 2025
EV/EBITDA 0.6×
FY 2018: 386×FY 2019: -18.3×FY 2020: -47.0×FY 2021: -508×FY 2022: -8.8×FY 2023: -9.6×FY 2024: -7.7×FY 2025: 0.6×
FY 2018 5y median -8.8× FY 2025
EV/Sales 0.0×
FY 2018: 10.3×FY 2019: 16.5×FY 2020: 60.5×FY 2021: 113×FY 2022: 20.2×FY 2023: 6.9×FY 2024: 16.2×FY 2025: 0.0×
FY 2018 5y median 16.2× FY 2025
FCF Yield -300.0%
FY 2018: 6.2%FY 2019: 1.0%FY 2020: -2.6%FY 2021: -1.3%FY 2022: -10.6%FY 2023: -16.8%FY 2024: -3.3%FY 2025: -300.0%
FY 2018 5y median -10.6% FY 2025

Profitability

Gross Margin 0.0%
FY 2018: 25.4%FY 2019: 18.4%FY 2020: 57.7%FY 2021: 79.5%FY 2022: 61.8%FY 2023: 72.0%FY 2024: 76.3%FY 2025: 0.0%
FY 2018 5y median 72.0% FY 2025
Operating Margin 0.0%
FY 2018: -54.4%FY 2019: -124.0%FY 2020: -180.8%FY 2021: -231.1%FY 2022: -332.4%FY 2023: -233.9%FY 2024: -345.8%FY 2025: 0.0%
FY 2018 5y median -233.9% FY 2025
Net Margin 0.0%
FY 2018: -231.1%FY 2019: -208.7%FY 2020: -215.3%FY 2021: -115.0%FY 2022: -334.4%FY 2023: -140.2%FY 2024: -280.1%FY 2025: 0.0%
FY 2018 5y median -140.2% FY 2025
ROE 66.7%
FY 2018: 1931.4%FY 2019: -405.4%FY 2020: -117.8%FY 2021: -25.3%FY 2022: -120.0%FY 2023: -65.4%FY 2024: 191.7%FY 2025: 66.7%
FY 2018 5y median -25.3% FY 2025
ROIC -161.7%
FY 2018: -16.1%FY 2019: -79.1%FY 2020: -45.9%FY 2021: -49.4%FY 2022: -74.9%FY 2023: -56.0%FY 2024: 21749.7%FY 2025: -161.7%
FY 2018 5y median -56.0% FY 2025
ROA 37.1%
FY 2018: -48.5%FY 2019: -55.7%FY 2020: -29.5%FY 2021: -13.3%FY 2022: -61.8%FY 2023: -24.2%FY 2024: -134.6%FY 2025: 37.1%
FY 2018 5y median -24.2% FY 2025

Growth (YoY)

Revenue -100.0%
FY 2018: 0.0%FY 2019: 10.9%FY 2020: -38.6%FY 2021: -18.3%FY 2022: -23.3%FY 2023: -2.8%FY 2024: -12.2%FY 2025: -100.0%
FY 2018 FY 2025
Operating Income 73.7%
FY 2018: 0.0%FY 2019: -152.4%FY 2020: 10.5%FY 2021: -4.4%FY 2022: -10.3%FY 2023: 31.6%FY 2024: -29.8%FY 2025: 73.7%
FY 2018 FY 2025
EPS (diluted) 53.3%
FY 2018: 0.0%FY 2019: 59.3%FY 2020: 70.8%FY 2021: 78.6%FY 2022: -17.3%FY 2023: 34.4%FY 2024: 47.4%FY 2025: 53.3%
FY 2018 FY 2025
Free Cash Flow -156.3%
FY 2018: 0.0%FY 2019: -60.0%FY 2020: -722.1%FY 2021: 22.5%FY 2022: -7.9%FY 2023: 40.4%FY 2024: 65.5%FY 2025: -156.3%
FY 2018 FY 2025

Financial Health

Current Ratio 2.3×
FY 2018: 0.4×FY 2019: 0.3×FY 2020: 0.6×FY 2021: 1.0×FY 2022: 2.1×FY 2023: 1.9×FY 2024: 0.4×FY 2025: 2.3×
FY 2018 5y median 1.9× FY 2025
Quick Ratio 2.3×
FY 2018: 0.2×FY 2019: 0.2×FY 2020: 0.6×FY 2021: 1.0×FY 2022: 1.8×FY 2023: 1.7×FY 2024: 0.2×FY 2025: 2.3×
FY 2018 5y median 1.7× FY 2025
Debt / Equity 0.0×
FY 2018: -28.1×FY 2019: 1.7×FY 2020: 0.4×FY 2021: 0.0×FY 2022: 0.6×FY 2023: 0.7×FY 2024: -1.0×FY 2025: 0.0×
FY 2018 5y median 0.0× FY 2025
Net Debt / EBITDA 1.1×
FY 2018: 119×FY 2019: -0.8×FY 2020: 0.8×FY 2021: 13.5×FY 2022: -0.0×FY 2023: 1.2×FY 2024: -0.3×FY 2025: 1.1×
FY 2018 5y median 1.1× FY 2025
Interest Coverage 0.0×
FY 2018: 0.0×FY 2019: -1.4×FY 2020: -5.7×FY 2021: -49.0×FY 2022: -33.4×FY 2023: -25.4×FY 2024: -31.5×FY 2025: 0.0×
FY 2018 5y median -31.5× FY 2025

Dividends

Dividend Yield 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 1635.4%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: -9029.5%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31